Attana AB offers biologically relevant information to improve efficiency and performance of pharmaceutical drug development.
2002
10
Last FY Revenue $0.4M
Last FY EBITDA -$0.5M
$3.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Attana achieved revenue of $0.4M and an EBITDA of -$0.5M.
Attana expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Attana valuation multiples based on analyst estimatesNTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|
Revenue | XXX | $0.4M | XXX | XXX | XXX |
Gross Profit | XXX | $0.6M | XXX | XXX | XXX |
Gross Margin | XXX | 145% | XXX | XXX | XXX |
EBITDA | XXX | -$0.5M | XXX | XXX | XXX |
EBITDA Margin | XXX | -114% | XXX | XXX | XXX |
EBIT | XXX | -$1.1M | XXX | XXX | XXX |
EBIT Margin | XXX | -244% | XXX | XXX | XXX |
Net Profit | XXX | -$1.3M | XXX | XXX | XXX |
Net Margin | XXX | -311% | XXX | XXX | XXX |
Net Debt | XXX | $0.1M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 3, 2025, Attana's stock price is SEK 0 (or $0).
Attana has current market cap of SEK 31.7M (or $3.3M), and EV of SEK 32.9M (or $3.5M).
See Attana trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$3.5M | $3.3M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 3, 2025, Attana has market cap of $3.3M and EV of $3.5M.
Attana's trades at 8.0x EV/Revenue multiple, and -7.0x EV/EBITDA.
Equity research analysts estimate Attana's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Attana's P/E ratio is not available.
See valuation multiples for Attana and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $3.3M | XXX | $3.3M | XXX | XXX | XXX |
EV (current) | $3.5M | XXX | $3.5M | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | 8.0x | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | -7.0x | XXX | XXX | XXX |
EV/EBIT | n/a | XXX | -3.3x | XXX | XXX | XXX |
EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
P/E | n/a | XXX | -2.5x | XXX | XXX | XXX |
EV/FCF | n/a | XXX | -7.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAttana's revenue per employee in the last FY averaged $43K, while opex per employee averaged $0.2M for the same period.
Attana's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Attana's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Attana and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | -114% | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $43K | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 389% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
Clarity Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
Cyclopharm | XXX | XXX | XXX | XXX | XXX | XXX |
Healius | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Attana acquired XXX companies to date.
Last acquisition by Attana was XXXXXXXX, XXXXX XXXXX XXXXXX . Attana acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Attana founded? | Attana was founded in 2002. |
Where is Attana headquartered? | Attana is headquartered in Sweden. |
How many employees does Attana have? | As of today, Attana has 10 employees. |
Is Attana publicy listed? | Yes, Attana is a public company listed on NGM. |
What is the stock symbol of Attana? | Attana trades under ATANA ticker. |
When did Attana go public? | Attana went public in 2018. |
Who are competitors of Attana? | Similar companies to Attana include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm. |
What is the current market cap of Attana? | Attana's current market cap is $3.3M |
Is Attana profitable? | Yes, Attana is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.